Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Peter Kabos

Concepts (430)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Breast Neoplasms
60
2026
2411
6.030
Why?
Receptors, Estrogen
24
2026
405
3.120
Why?
Estrogen Receptor alpha
6
2025
154
1.470
Why?
Receptors, Progesterone
13
2025
241
1.450
Why?
Brain Neoplasms
16
2026
1324
1.120
Why?
Estradiol
4
2025
517
0.990
Why?
Aging, Premature
1
2025
18
0.910
Why?
High-Intensity Interval Training
1
2025
45
0.870
Why?
Antibiotics, Antineoplastic
1
2025
140
0.840
Why?
Doxorubicin
4
2025
414
0.840
Why?
Chromatin
2
2026
557
0.820
Why?
Estrogens
8
2026
364
0.800
Why?
Antineoplastic Combined Chemotherapy Protocols
12
2025
1996
0.790
Why?
Keratin-5
6
2022
43
0.780
Why?
Triple Negative Breast Neoplasms
6
2023
219
0.740
Why?
Breast Neoplasms, Male
3
2018
29
0.730
Why?
Stem Cells
8
2006
612
0.700
Why?
Biomarkers, Tumor
7
2022
1334
0.700
Why?
Tetrahydronaphthalenes
1
2021
34
0.650
Why?
Antineoplastic Agents, Hormonal
7
2025
196
0.640
Why?
MCF-7 Cells
5
2025
133
0.630
Why?
Neoplasm Metastasis
4
2020
693
0.630
Why?
Immunoprecipitation
4
2020
150
0.630
Why?
Drug Resistance, Neoplasm
5
2025
889
0.610
Why?
Neoplastic Cells, Circulating
1
2020
81
0.600
Why?
Neurons
9
2026
1663
0.600
Why?
Brain Edema
2
2023
63
0.600
Why?
Benzodiazepines
1
2021
156
0.600
Why?
Female
63
2026
79080
0.580
Why?
Radiosurgery
3
2023
398
0.570
Why?
Carcinoma, Intraductal, Noninfiltrating
2
2017
61
0.560
Why?
Epithelial-Mesenchymal Transition
1
2020
218
0.550
Why?
Artifacts
2
2016
142
0.550
Why?
Binding Sites
2
2025
1306
0.550
Why?
Leukocytes, Mononuclear
2
2020
585
0.540
Why?
Gene Expression Regulation, Neoplastic
11
2025
1429
0.520
Why?
Gene Expression Profiling
7
2020
1790
0.520
Why?
Fanconi Anemia Complementation Group N Protein
1
2017
4
0.500
Why?
Polyadenylation
1
2017
41
0.500
Why?
Neoplastic Stem Cells
7
2020
402
0.500
Why?
High-Throughput Nucleotide Sequencing
4
2019
538
0.500
Why?
Protein Kinase Inhibitors
7
2025
982
0.500
Why?
Organoplatinum Compounds
1
2016
65
0.490
Why?
Carcinogenesis
2
2020
226
0.480
Why?
Cancer-Associated Fibroblasts
1
2016
23
0.480
Why?
Piperazines
5
2025
367
0.470
Why?
Humans
76
2026
145625
0.470
Why?
Cell Line, Tumor
17
2026
3538
0.460
Why?
Pyridines
6
2025
606
0.460
Why?
Fluorouracil
1
2016
231
0.450
Why?
CD146 Antigen
3
2021
38
0.450
Why?
Mitochondrial Proteins
1
2017
263
0.440
Why?
Microscopy, Electron, Scanning Transmission
1
2014
3
0.430
Why?
Thrombocytopenia
1
2016
205
0.430
Why?
Microwaves
1
2014
29
0.420
Why?
Maytansine
1
2014
18
0.420
Why?
Cell-Free Nucleic Acids
2
2026
39
0.410
Why?
Microscopy
1
2014
147
0.380
Why?
Trastuzumab
5
2023
119
0.370
Why?
Receptors, Cytoplasmic and Nuclear
1
2014
210
0.360
Why?
Receptor, Fibroblast Growth Factor, Type 1
2
2026
59
0.360
Why?
Progestins
6
2025
67
0.360
Why?
Neoplasms, Hormone-Dependent
1
2012
33
0.360
Why?
Tamoxifen
5
2025
193
0.360
Why?
RNA-Binding Proteins
1
2016
463
0.350
Why?
Antineoplastic Agents
4
2023
2218
0.350
Why?
Analgesics, Opioid
1
2021
1158
0.350
Why?
RNA Polymerase III
2
2025
34
0.350
Why?
Tumor Microenvironment
4
2021
745
0.350
Why?
Homeodomain Proteins
5
2018
525
0.350
Why?
MicroRNAs
5
2016
695
0.340
Why?
Chemotherapy, Adjuvant
5
2023
429
0.330
Why?
RNA
2
2016
925
0.330
Why?
Repressor Proteins
2
2025
428
0.330
Why?
Neoplasm Recurrence, Local
5
2021
1156
0.320
Why?
Cancer Survivors
2
2026
347
0.320
Why?
Mutation
3
2021
4082
0.310
Why?
Image Processing, Computer-Assisted
1
2014
774
0.310
Why?
Neoadjuvant Therapy
3
2021
474
0.310
Why?
Antibodies, Monoclonal, Humanized
2
2021
992
0.290
Why?
Tumor Cells, Cultured
7
2020
878
0.290
Why?
Astrocytes
6
2026
229
0.290
Why?
Pyrimidines
3
2018
530
0.290
Why?
Liver Neoplasms
1
2015
774
0.280
Why?
Middle Aged
20
2026
36359
0.280
Why?
Neoplasm Staging
5
2026
1486
0.280
Why?
Carcinoma, Ductal, Breast
2
2020
91
0.280
Why?
Hydrocephalus
3
2023
114
0.280
Why?
Signal Transduction
6
2026
5234
0.280
Why?
Colorectal Neoplasms
1
2016
870
0.270
Why?
Prognosis
7
2021
4331
0.270
Why?
Adenocarcinoma
1
2015
927
0.270
Why?
Bone Marrow Cells
2
2014
326
0.260
Why?
Adult
21
2026
40821
0.240
Why?
Aged
17
2025
26251
0.240
Why?
Neural Cell Adhesion Molecules
1
2026
38
0.240
Why?
Helix-Loop-Helix Motifs
2
2002
12
0.230
Why?
Necrosis
2
2019
243
0.230
Why?
Fibroblast Growth Factor 2
1
2026
93
0.230
Why?
Cluster Analysis
4
2019
494
0.230
Why?
Aged, 80 and over
7
2025
8351
0.230
Why?
Chondroitin Sulfate Proteoglycans
2
2006
10
0.220
Why?
Fatty Acid Synthase, Type I
1
2025
11
0.220
Why?
Sequence Analysis, RNA
2
2019
441
0.220
Why?
Protein Binding
2
2025
2239
0.220
Why?
STAT1 Transcription Factor
1
2025
68
0.220
Why?
Neuroglia
2
2003
176
0.220
Why?
Neoplasm Grading
2
2017
313
0.210
Why?
Weight Reduction Programs
1
2026
140
0.210
Why?
RNA, Transfer
1
2025
142
0.210
Why?
Mice, Inbred NOD
5
2021
598
0.210
Why?
Genetic Therapy
2
2003
303
0.210
Why?
Animals
28
2026
38030
0.200
Why?
Aminopyridines
2
2025
128
0.200
Why?
Carbolines
1
2024
35
0.200
Why?
Disease-Free Survival
4
2024
777
0.200
Why?
Triazines
1
2024
48
0.200
Why?
Aromatase Inhibitors
2
2021
81
0.200
Why?
Progesterone
3
2014
214
0.200
Why?
Mice
20
2026
18266
0.200
Why?
Benzimidazoles
2
2025
189
0.200
Why?
Obesity
3
2026
3123
0.190
Why?
Morpholines
1
2024
130
0.190
Why?
Promoter Regions, Genetic
3
2025
1236
0.190
Why?
Extracellular Matrix Proteins
1
2004
156
0.190
Why?
Telomere
1
2026
300
0.190
Why?
Keratin-17
1
2022
4
0.190
Why?
Aquaporin 4
2
2023
101
0.180
Why?
Nerve Regeneration
1
2002
57
0.180
Why?
Triglycerides
1
2025
527
0.180
Why?
Mice, SCID
4
2020
360
0.180
Why?
Tumor Suppressor Proteins
2
2015
314
0.180
Why?
Down-Regulation
4
2015
612
0.180
Why?
Stromal Cells
2
2020
123
0.180
Why?
Glioma
5
2006
425
0.180
Why?
Class I Phosphatidylinositol 3-Kinases
2
2025
109
0.180
Why?
Immunoconjugates
1
2023
138
0.180
Why?
Neoplasm Invasiveness
3
2020
503
0.170
Why?
Interleukin-13 Receptor alpha2 Subunit
1
2021
5
0.170
Why?
Cyclins
1
2002
77
0.170
Why?
Transcription, Genetic
2
2025
1429
0.170
Why?
Overweight
1
2026
613
0.170
Why?
Tumor Suppressor Protein p53
2
2015
530
0.170
Why?
Lipid Metabolism
1
2025
533
0.170
Why?
Medicare
3
2023
907
0.170
Why?
Insulin Receptor Substrate Proteins
1
2020
55
0.160
Why?
Brain
3
2026
2981
0.160
Why?
Gene Regulatory Networks
2
2014
319
0.160
Why?
Cell Adhesion Molecules
1
2021
180
0.160
Why?
Disease Progression
5
2026
2857
0.160
Why?
gamma-Aminobutyric Acid
1
2002
195
0.160
Why?
Cancer Care Facilities
1
2020
48
0.160
Why?
Meningeal Carcinomatosis
1
2020
7
0.160
Why?
RNA, Messenger
3
2019
2783
0.150
Why?
Antigens, Neoplasm
1
2021
271
0.150
Why?
Hyaluronan Receptors
4
2014
105
0.150
Why?
Cell Proliferation
6
2025
2497
0.150
Why?
Retrospective Studies
6
2025
17291
0.150
Why?
SEER Program
1
2021
233
0.150
Why?
Gene Library
2
2019
121
0.150
Why?
Antineoplastic Agents, Immunological
2
2019
200
0.150
Why?
Carcinoma, Lobular
1
2020
59
0.150
Why?
Collagen
2
2020
460
0.150
Why?
Transcriptome
2
2019
1066
0.150
Why?
Lymphatic Metastasis
2
2017
335
0.140
Why?
ErbB Receptors
2
2020
636
0.140
Why?
Treatment Outcome
6
2025
11744
0.140
Why?
Paclitaxel
1
2020
258
0.140
Why?
beta Catenin
1
2020
250
0.130
Why?
Xenograft Model Antitumor Assays
4
2017
928
0.130
Why?
Heterografts
4
2020
143
0.130
Why?
3' Untranslated Regions
1
2017
152
0.120
Why?
Feasibility Studies
2
2026
1125
0.120
Why?
Pyrroles
1
2017
221
0.120
Why?
Quinolines
3
2025
191
0.120
Why?
Receptors, Androgen
1
2017
149
0.120
Why?
Genital Neoplasms, Female
1
2017
100
0.120
Why?
Neoplasms, Radiation-Induced
1
2016
100
0.120
Why?
Gene Expression
2
2016
1461
0.120
Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2016
973
0.110
Why?
Neoplasms, Second Primary
1
2016
103
0.110
Why?
Ovary
1
2017
235
0.110
Why?
Single-Cell Analysis
1
2019
366
0.110
Why?
Combined Modality Therapy
2
2019
1269
0.110
Why?
Ribosomal Proteins
1
2015
93
0.110
Why?
Proto-Oncogene Proteins c-akt
1
2017
438
0.110
Why?
Paracrine Communication
1
2015
67
0.110
Why?
DNA Primers
1
2016
487
0.110
Why?
Cell Movement
4
2026
950
0.110
Why?
Isoquinolines
2
2025
44
0.110
Why?
Azetidines
2
2025
45
0.110
Why?
Risk Reduction Behavior
1
2016
219
0.110
Why?
Hodgkin Disease
1
2016
173
0.110
Why?
Oxazoles
2
2025
48
0.110
Why?
STAT5 Transcription Factor
1
2014
50
0.100
Why?
Reactive Oxygen Species
1
2017
610
0.100
Why?
Azepines
1
2015
104
0.100
Why?
Pyrazoles
1
2018
516
0.100
Why?
Odds Ratio
1
2017
1070
0.100
Why?
Fibroblasts
1
2020
1033
0.100
Why?
Receptors, Steroid
1
2014
41
0.100
Why?
Microscopy, Atomic Force
1
2014
125
0.100
Why?
Apoptosis
4
2017
2436
0.100
Why?
Peptides
1
2020
991
0.100
Why?
Software
2
2019
673
0.100
Why?
Clinical Decision-Making
1
2017
364
0.100
Why?
Quinazolines
2
2025
267
0.090
Why?
DNA-Binding Proteins
2
2015
1467
0.090
Why?
CD24 Antigen
1
2012
18
0.090
Why?
Nucleosomes
2
2026
168
0.090
Why?
Sensitivity and Specificity
2
2016
1992
0.090
Why?
Male
9
2026
73014
0.090
Why?
Retinoids
1
2012
34
0.090
Why?
RNA Interference
1
2014
470
0.090
Why?
Anthracyclines
2
2023
49
0.090
Why?
Opioid-Related Disorders
1
2021
611
0.090
Why?
Disease Models, Animal
4
2017
4565
0.090
Why?
Cell Differentiation
4
2004
1979
0.090
Why?
Taxoids
2
2023
115
0.090
Why?
Comorbidity
1
2017
1652
0.090
Why?
Clinical Trials as Topic
1
2017
1062
0.090
Why?
Extracellular Signal-Regulated MAP Kinases
1
2012
173
0.090
Why?
Genome, Human
1
2014
425
0.090
Why?
Drug Discovery
1
2012
153
0.080
Why?
Small Molecule Libraries
1
2012
113
0.080
Why?
Rats
5
2017
5574
0.080
Why?
United States
4
2023
16041
0.080
Why?
Tumor Burden
1
2012
326
0.080
Why?
Logistic Models
1
2016
2112
0.080
Why?
Mitochondria
1
2017
996
0.080
Why?
Oligonucleotide Array Sequence Analysis
1
2012
751
0.080
Why?
Estrogen Antagonists
1
2010
37
0.080
Why?
Dendritic Cells
2
2004
507
0.080
Why?
Time Factors
3
2020
7079
0.080
Why?
Nuclear Proteins
1
2015
739
0.080
Why?
Lung Neoplasms
1
2023
2674
0.070
Why?
Transforming Growth Factor beta
1
2012
466
0.070
Why?
BRCA2 Protein
1
2009
68
0.070
Why?
Cell Culture Techniques
2
2020
371
0.070
Why?
Pregnancy Complications, Neoplastic
1
2009
64
0.070
Why?
Administration, Oral
2
2024
867
0.070
Why?
Thrombophilia
1
2009
89
0.070
Why?
Receptors, CXCR4
2
2006
90
0.070
Why?
Practice Patterns, Physicians'
1
2017
1370
0.070
Why?
Cells, Cultured
3
2006
4112
0.070
Why?
Tumor Necrosis Factor-alpha
2
2002
1223
0.070
Why?
Stem Cell Transplantation
3
2004
189
0.060
Why?
Proteoglycans
2
2006
111
0.060
Why?
Immunohistochemistry
2
2017
1709
0.060
Why?
Radiotherapy, Adjuvant
2
2018
222
0.060
Why?
Genetic Predisposition to Disease
1
2016
2455
0.060
Why?
Rats, Sprague-Dawley
2
2002
2533
0.060
Why?
Aurora Kinase A
2
2018
57
0.060
Why?
Dyskeratosis Congenita
1
2026
11
0.060
Why?
Algorithms
1
2014
1843
0.060
Why?
Risk Factors
2
2020
10840
0.060
Why?
Drug Delivery Systems
1
2010
377
0.060
Why?
Proof of Concept Study
1
2026
89
0.060
Why?
Severity of Illness Index
1
2014
2910
0.060
Why?
Biopsy
2
2020
1073
0.060
Why?
Transcription Factor TFIIIB
1
2025
5
0.060
Why?
TATA-Binding Protein Associated Factors
1
2025
23
0.060
Why?
Nervous System
1
2006
68
0.060
Why?
Rats, Inbred F344
2
2003
266
0.060
Why?
Mass Spectrometry
2
2020
728
0.060
Why?
Cyclin-Dependent Kinase 4
1
2025
52
0.060
Why?
Neoplasm Transplantation
2
2016
238
0.060
Why?
Cyclin-Dependent Kinase 6
1
2025
49
0.060
Why?
Tomography, X-Ray Computed
1
2015
2766
0.050
Why?
Infant, Premature, Diseases
1
2006
113
0.050
Why?
Receptor-Like Protein Tyrosine Phosphatases, Class 5
1
2004
1
0.050
Why?
Aggrecans
1
2004
15
0.050
Why?
Purines
1
2025
188
0.050
Why?
Lectins, C-Type
1
2004
61
0.050
Why?
Cell Line
2
2014
2809
0.050
Why?
Cyclophosphamide
2
2018
275
0.050
Why?
Maximum Tolerated Dose
1
2024
216
0.050
Why?
Hemangioma, Cavernous, Central Nervous System
1
2003
8
0.050
Why?
Mastectomy, Segmental
2
2017
107
0.050
Why?
Adipose Tissue
2
2018
641
0.050
Why?
Follow-Up Studies
2
2025
5397
0.050
Why?
Inhibitor of Differentiation Protein 2
1
2002
5
0.050
Why?
Bridged-Ring Compounds
1
2023
31
0.050
Why?
Inhibitor of Differentiation Protein 1
1
2002
8
0.050
Why?
Glioblastoma
2
2006
349
0.050
Why?
Aromatase
1
2023
37
0.050
Why?
Camptothecin
1
2023
139
0.050
Why?
Neoplasms, Multiple Primary
1
2003
57
0.050
Why?
Edema
1
2023
129
0.050
Why?
Hepatocyte Nuclear Factor 3-alpha
1
2022
9
0.050
Why?
Pyramidal Tracts
1
2002
30
0.050
Why?
Sciatic Nerve
1
2002
63
0.050
Why?
Neurites
1
2002
51
0.050
Why?
Mice, Inbred C57BL
5
2004
6021
0.050
Why?
Vimentin
1
2022
47
0.050
Why?
Gonadotropin-Releasing Hormone
1
2024
215
0.040
Why?
Transcription Factor HES-1
1
2002
5
0.040
Why?
Interleukin-12
1
2002
115
0.040
Why?
Phenotype
1
2010
3186
0.040
Why?
Blotting, Western
1
2004
1176
0.040
Why?
Frontal Lobe
1
2002
159
0.040
Why?
Cyclin-Dependent Kinase Inhibitor p21
1
2002
104
0.040
Why?
Fibroblast Growth Factors
1
2002
187
0.040
Why?
Mice, Inbred BALB C
1
2004
1244
0.040
Why?
Oligonucleotides, Antisense
1
2002
122
0.040
Why?
Ependymoma
1
2003
177
0.040
Why?
Protein-Lysine 6-Oxidase
1
2020
14
0.040
Why?
Clinical Trials, Phase I as Topic
1
2020
49
0.040
Why?
Cerebral Cortex
1
2004
481
0.040
Why?
TOR Serine-Threonine Kinases
1
2024
454
0.040
Why?
Hospitals, University
1
2021
176
0.040
Why?
Weight Loss
1
2026
857
0.040
Why?
Nervous System Diseases
1
2003
286
0.040
Why?
Adherens Junctions
1
2020
24
0.040
Why?
Membrane Glycoproteins
1
2002
495
0.040
Why?
Neoplasms
1
2015
2944
0.040
Why?
Animals, Newborn
1
2002
887
0.040
Why?
Dose-Response Relationship, Drug
1
2024
2018
0.040
Why?
Gene Knockout Techniques
1
2020
122
0.040
Why?
Protein Interaction Mapping
1
2020
105
0.040
Why?
Patient Acceptance of Health Care
1
2026
880
0.040
Why?
Interferon-gamma
1
2002
780
0.040
Why?
Kaplan-Meier Estimate
1
2021
959
0.040
Why?
Mice, Nude
2
2015
665
0.040
Why?
DNA, Complementary
1
2019
269
0.030
Why?
beta-Galactosidase
3
2002
73
0.030
Why?
Loss of Function Mutation
1
2018
47
0.030
Why?
Maintenance Chemotherapy
1
2018
41
0.030
Why?
Cadherins
1
2020
201
0.030
Why?
Nausea
1
2018
111
0.030
Why?
Immunotherapy
1
2003
669
0.030
Why?
Wnt Signaling Pathway
1
2020
211
0.030
Why?
Breast
1
2018
154
0.030
Why?
Phenylthiohydantoin
1
2017
44
0.030
Why?
Diarrhea
1
2018
190
0.030
Why?
Mammary Neoplasms, Experimental
1
2017
61
0.030
Why?
Area Under Curve
1
2017
333
0.030
Why?
Mastectomy
1
2018
188
0.030
Why?
Ovariectomy
1
2017
164
0.030
Why?
Antigens, CD
1
2020
559
0.030
Why?
Steroids
1
2017
160
0.030
Why?
Benzamides
1
2017
226
0.030
Why?
Cell Membrane
1
2020
701
0.030
Why?
Nitriles
1
2017
211
0.030
Why?
Fatigue
1
2018
362
0.030
Why?
Flow Cytometry
2
2012
1160
0.030
Why?
Apoptosis Regulatory Proteins
2
2009
186
0.030
Why?
Proto-Oncogene Proteins c-mdm2
1
2015
66
0.030
Why?
Chromatography, Liquid
1
2017
452
0.030
Why?
Tumor Protein p73
1
2015
18
0.030
Why?
Postmenopause
1
2017
394
0.030
Why?
Gene Knockdown Techniques
1
2015
334
0.030
Why?
Transcription Factors
1
2002
1728
0.030
Why?
Weight Gain
1
2018
561
0.030
Why?
Molecular Targeted Therapy
1
2017
446
0.030
Why?
Serrate-Jagged Proteins
1
2014
27
0.030
Why?
Jagged-1 Protein
1
2014
22
0.030
Why?
Wnt-5a Protein
1
2014
25
0.030
Why?
Argonaute Proteins
1
2014
32
0.030
Why?
Matrix Metalloproteinase 2
1
2014
57
0.030
Why?
Cell Transformation, Neoplastic
1
2015
314
0.020
Why?
Testosterone
1
2017
419
0.020
Why?
Cellular Microenvironment
1
2014
94
0.020
Why?
Gene Expression Regulation
1
2022
2591
0.020
Why?
Wnt Proteins
1
2014
131
0.020
Why?
Interleukin-6
1
2017
782
0.020
Why?
Guideline Adherence
1
2017
585
0.020
Why?
Acitretin
1
2012
3
0.020
Why?
Miconazole
1
2012
5
0.020
Why?
Socioeconomic Factors
1
2017
1323
0.020
Why?
Calcium-Binding Proteins
1
2014
219
0.020
Why?
Isotretinoin
1
2012
27
0.020
Why?
Intercellular Signaling Peptides and Proteins
1
2014
372
0.020
Why?
Luciferases
1
2012
153
0.020
Why?
Genes, Reporter
1
2012
273
0.020
Why?
Tretinoin
1
2012
114
0.020
Why?
Vascular Endothelial Growth Factor A
1
2014
543
0.020
Why?
Biomarkers
2
2017
4329
0.020
Why?
Risk Assessment
1
2020
3678
0.020
Why?
Green Fluorescent Proteins
1
2012
407
0.020
Why?
Proto-Oncogene Proteins
1
2014
615
0.020
Why?
Diet
1
2018
1271
0.020
Why?
Base Sequence
1
2014
2119
0.020
Why?
Magnetic Resonance Imaging
2
2019
3917
0.020
Why?
Colorado
1
2020
4588
0.020
Why?
HEK293 Cells
1
2012
746
0.020
Why?
Age Factors
1
2017
3321
0.020
Why?
Hypertension
1
2018
1270
0.020
Why?
Molecular Sequence Data
1
2014
2835
0.020
Why?
Pregnancy Trimester, Second
1
2009
91
0.020
Why?
Practice Guidelines as Topic
1
2017
1581
0.020
Why?
Pregnancy Trimester, First
1
2009
139
0.020
Why?
Lymph Node Excision
1
2009
173
0.020
Why?
Transplantation, Heterologous
1
2008
165
0.020
Why?
Endothelial Cells
1
2014
876
0.020
Why?
Membrane Proteins
1
2014
1130
0.020
Why?
Neoplasms, Experimental
1
2008
163
0.020
Why?
CD8-Positive T-Lymphocytes
2
2002
929
0.010
Why?
Chemokines, CXC
1
2006
68
0.010
Why?
Nestin
1
2006
19
0.010
Why?
Laminin
1
2006
72
0.010
Why?
Intermediate Filament Proteins
1
2006
34
0.010
Why?
CD4-Positive T-Lymphocytes
2
2002
1148
0.010
Why?
Chemokine CXCL12
1
2006
85
0.010
Why?
Infant, Newborn
2
2009
6449
0.010
Why?
Lasers
1
2006
127
0.010
Why?
Glial Fibrillary Acidic Protein
1
2006
124
0.010
Why?
Drug Combinations
1
2006
399
0.010
Why?
Adolescent
1
2024
22451
0.010
Why?
Culture Media, Conditioned
1
2004
112
0.010
Why?
RNA, Small Interfering
1
2006
630
0.010
Why?
Injections, Intralesional
1
2003
34
0.010
Why?
TNF-Related Apoptosis-Inducing Ligand
1
2002
54
0.010
Why?
3T3 Cells
1
2002
152
0.010
Why?
Random Allocation
1
2003
365
0.010
Why?
Nerve Tissue Proteins
1
2006
594
0.010
Why?
Models, Neurological
1
2004
252
0.010
Why?
Adenoviridae
1
2002
196
0.010
Why?
Reference Values
1
2003
787
0.010
Why?
Infant, Premature
1
2006
622
0.010
Why?
Genetic Vectors
1
2002
326
0.010
Why?
Transfection
1
2002
914
0.010
Why?
Oligodendroglia
1
2002
198
0.010
Why?
Recombinant Fusion Proteins
1
2002
662
0.010
Why?
Case-Control Studies
1
2006
3633
0.010
Why?
Survival Rate
1
2003
2078
0.010
Why?
Pregnancy
1
2009
7217
0.010
Why?
Vaccination
1
2003
1444
0.010
Why?
Prospective Studies
1
2006
8087
0.010
Why?
Infant
1
2006
10093
0.010
Why?
Kabos's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)